The role of glycosyltransferase enzyme GCNT3 in colon and ovarian cancer prognosis and chemoresistance
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The role of glycosyltransferase enzyme GCNT3 in colon and ovarian cancer prognosis and chemoresistance ; volume:8 ; number:1 ; day:31 ; month:5 ; year:2018 ; pages:1-13 ; date:12.2018
Scientific reports ; 8, Heft 1 (31.5.2018), 1-13, 12.2018
- Urheber
-
Fernández, Lara P.
- Beteiligte Personen und Organisationen
-
Sánchez-Martínez, Ruth
Vargas, Teodoro
Herranz, Jesús
Martín-Hernández, Roberto
Mendiola, Marta
Hardisson, David
Reglero, Guillermo
Feliu, Jaime
Redondo, Andrés
Ramírez de Molina, Ana
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-26468-4
- URN
-
urn:nbn:de:101:1-2018080515352987835876
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Fernández, Lara P.
- Sánchez-Martínez, Ruth
- Vargas, Teodoro
- Herranz, Jesús
- Martín-Hernández, Roberto
- Mendiola, Marta
- Hardisson, David
- Reglero, Guillermo
- Feliu, Jaime
- Redondo, Andrés
- Ramírez de Molina, Ana
- SpringerLink (Online service)
Ähnliche Objekte (12)
Abnormal methylation characteristics predict chemoresistance and poor prognosis in advanced high-grade serous ovarian cancer
Tumor evolution and chemoresistance in ovarian cancer
Sox2 promotes expression of the ST6Gal-I glycosyltransferase in ovarian cancer cells
A signature based on glycosyltransferase genes provides a promising tool for the prediction of prognosis and immunotherapy responsiveness in ovarian cancer
Unveiling novel biomarkers for platinum chemoresistance in ovarian cancer
Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer
TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer
Chemoresistance is mediated by ovarian cancer leader cells in vitro
The SP1-12LOX axis promotes chemoresistance and metastasis of ovarian cancer
Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis
Dysregulation of lnc-SNHG1 and miR-216b-5p correlate with chemoresistance and indicate poor prognosis of serous epithelial ovarian cancer
Abnormal methylation characteristics predict chemoresistance and poor prognosis in advanced high-grade serous ovarian cancer
Tumor evolution and chemoresistance in ovarian cancer
Sox2 promotes expression of the ST6Gal-I glycosyltransferase in ovarian cancer cells
A signature based on glycosyltransferase genes provides a promising tool for the prediction of prognosis and immunotherapy responsiveness in ovarian cancer
Unveiling novel biomarkers for platinum chemoresistance in ovarian cancer
Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer
TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer
Chemoresistance is mediated by ovarian cancer leader cells in vitro
The SP1-12LOX axis promotes chemoresistance and metastasis of ovarian cancer
Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis
Dysregulation of lnc-SNHG1 and miR-216b-5p correlate with chemoresistance and indicate poor prognosis of serous epithelial ovarian cancer
Abnormal methylation characteristics predict chemoresistance and poor prognosis in advanced high-grade serous ovarian cancer
Tumor evolution and chemoresistance in ovarian cancer
Sox2 promotes expression of the ST6Gal-I glycosyltransferase in ovarian cancer cells
A signature based on glycosyltransferase genes provides a promising tool for the prediction of prognosis and immunotherapy responsiveness in ovarian cancer
Unveiling novel biomarkers for platinum chemoresistance in ovarian cancer
Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer
TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer
Chemoresistance is mediated by ovarian cancer leader cells in vitro
The SP1-12LOX axis promotes chemoresistance and metastasis of ovarian cancer
Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis